Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Dick

Showing results (1-10 of 178) with videos related to

Pageof 18
Sort By:
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists|December 5, 2015
Alternative approaches to well-being and engagement in VanuatuThomas Dick
Frontiers in Microbiology|March 17, 2020
Rifabutin: A Repurposing Candidate for <i>Mycobacterium abscessus</i> Lung DiseaseThomas Dick
The Journal of Experimental Medicine|May 11, 2022
Drug development challenges in nontuberculous mycobacterial lung disease: TB to the rescueVéronique Dartois, Thomas Dick
Future Microbiology|June 29, 2011
How antibacterials really work: impact on drug discoveryThomas Dick, Douglas Young
Nature Reviews. Drug Discovery|February 28, 2024
Therapeutic developments for tuberculosis and nontuberculous mycobacterial lung diseaseVéronique Dartois, Thomas Dick
FEMS Microbiology Letters|November 1, 2003
Isoniazid resistance of exponentially growing Mycobacterium smegmatis biofilm cultureRaymond Teng, Thomas Dick
The Journal of Antimicrobial Chemotherapy|May 20, 2004
Role for malonyl coenzyme A:acyl carrier protein transacylase (MCAT) in the growth-inhibitory effect of the calmodulin antagonist trifluoperazine in Mycobacterium bovis BCGIndrajit Sinha, Thomas Dick
Nature Microbiology|August 26, 2018
TB drug susceptibility is more than MICThomas Dick, Véronique Dartois
Chemistry & Biology|January 24, 2015
Antibacterial drug discovery: doing it rightMartin Gengenbacher, Thomas Dick
Frontiers in Microbiology|August 31, 2018
Mycobacterial Cell Wall Synthesis Inhibitors Cause Lethal ATP BurstAnnanya Shetty, Thomas Dick
Pageof 18

Showing results (1-10 of 178) with videos related to

Sort By:
Pageof 18
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists|December 5, 2015
Alternative approaches to well-being and engagement in VanuatuThomas Dick
Frontiers in Microbiology|March 17, 2020
Rifabutin: A Repurposing Candidate for <i>Mycobacterium abscessus</i> Lung DiseaseThomas Dick
The Journal of Experimental Medicine|May 11, 2022
Drug development challenges in nontuberculous mycobacterial lung disease: TB to the rescueVéronique Dartois, Thomas Dick
Future Microbiology|June 29, 2011
How antibacterials really work: impact on drug discoveryThomas Dick, Douglas Young
Nature Reviews. Drug Discovery|February 28, 2024
Therapeutic developments for tuberculosis and nontuberculous mycobacterial lung diseaseVéronique Dartois, Thomas Dick
FEMS Microbiology Letters|November 1, 2003
Isoniazid resistance of exponentially growing Mycobacterium smegmatis biofilm cultureRaymond Teng, Thomas Dick
The Journal of Antimicrobial Chemotherapy|May 20, 2004
Role for malonyl coenzyme A:acyl carrier protein transacylase (MCAT) in the growth-inhibitory effect of the calmodulin antagonist trifluoperazine in Mycobacterium bovis BCGIndrajit Sinha, Thomas Dick
Nature Microbiology|August 26, 2018
TB drug susceptibility is more than MICThomas Dick, Véronique Dartois
Chemistry & Biology|January 24, 2015
Antibacterial drug discovery: doing it rightMartin Gengenbacher, Thomas Dick
Frontiers in Microbiology|August 31, 2018
Mycobacterial Cell Wall Synthesis Inhibitors Cause Lethal ATP BurstAnnanya Shetty, Thomas Dick
Pageof 18